• 제목/요약/키워드: Lymphatic Diseases

검색결과 65건 처리시간 0.017초

Lymphatic Intervention, the Frontline of Modern Lymphatic Medicine: Part II. Classification and Treatment of the Lymphatic Disorders

  • Saebeom Hur;Jinoo Kim;Lakshmi Ratnam;Maxim Itkin
    • Korean Journal of Radiology
    • /
    • 제24권2호
    • /
    • pp.109-132
    • /
    • 2023
  • Lymphatic disorders encompass a broad spectrum of diseases involving the lymphatic system, ranging from traumatic lymphatic leaks to lymphatic malformations. Lymphatic disorders can be categorized into traumatic and non-traumatic disorders according to their etiology. These two categories may be further divided into subgroups depending on the anatomical location of the lymphatic pathology and their association with clinical syndromes. Thoracic duct embolization was a milestone in the field of lymphatic intervention that encouraged the application of percutaneous embolization techniques to treat leaks and reflux disorders in the lymphatic system. Additional access routes for embolization, including retrograde thoracic duct and transhepatic lymphatic access, have also been developed. This article comprehensively reviews a variety of options for the treatment of lymphatic disorders, from conservative management to the most recent embolization techniques.

Nano-sized Drug Carriers and Key Factors for Lymphatic Delivery

  • Choi, Ji-Hoon;Lee, Yong-Bok
    • Journal of Pharmaceutical Investigation
    • /
    • 제40권spc호
    • /
    • pp.75-82
    • /
    • 2010
  • Specific diseases like cancer and acquired immune deficiency syndrome (AIDS) occur at various organs including lymphatics and spread through lymphatic system. Thus, if therapeutic agents for such diseases are more distributed or targeted to lymphatic system, we can obtain several advantages like reduction of systemic side effect and increase of efficacy. For these reasons, much interest has been focused on the nature of lymphatics and a lot of studies for lymphatic delivery of drugs have been carried out. Because lymphatics consist of single layer endothelium and have high permeability compared with blood capillaries, especially, the studies using nano-sized carriers have been performed. Polymeric nano-particle, liposome, and lipid-based vehicle have been adopted for lymphatic delivery as carriers. According to the administration route and the kind of carrier, the extent of lymphatic delivery efficiency of nano-sized carriers has been changed and influenced by several factors such as size, charge, hydrophobicity and surface feature of carrier. In this review, we summarized the key factors which affect lymphatic uptake and the major features of carriers for achieving the lymphatic delivery. Lymphatic delivery of drug using nano-sized carriers has many fold improved ability of lymphatic delivery compared with that of conventional dosage forms, but it has not shown whole lymph selectivity yet. Even though nano-sized carriers still have the potential and worth to study as lymphatic drug delivery technology as before, full understanding of delivery mechanism and influencing factors, and setting of pharmacokinetic model are required for more ideal lymphatic delivery of drug.

A novel role of Hippo-Yap/TAZ signaling pathway in lymphatic vascular development

  • Cha, Boksik;Moon, Sungjin;Kim, Wantae
    • BMB Reports
    • /
    • 제54권6호
    • /
    • pp.285-294
    • /
    • 2021
  • The lymphatic vasculature plays important role in regulating fluid homeostasis, intestinal lipid absorption, and immune surveillance in humans. Malfunction of lymphatic vasculature leads to several human diseases. Understanding the fundamental mechanism in lymphatic vascular development not only expand our knowledge, but also provide a new therapeutic insight. Recently, Hippo-YAP/TAZ signaling pathway, a key mechanism of organ size and tissue homeostasis, has emerged as a critical player that regulate lymphatic specification, sprouting, and maturation. In this review, we discuss the mechanistic regulation and pathophysiological significant of Hippo pathway in lymphatic vascular development.

A Tale of Two Models: Mouse and Zebrafish as Complementary Models for Lymphatic Studies

  • Kim, Jun-Dae;Jin, Suk-Won
    • Molecules and Cells
    • /
    • 제37권7호
    • /
    • pp.503-510
    • /
    • 2014
  • Lymphatic vessels provide essential roles in maintaining fluid homeostasis and lipid absorption. Dysfunctions of the lymphatic vessels lead to debilitating pathological conditions, collectively known as lymphedema. In addition, lymphatic vessels are a critical moderator for the onset and progression of diverse human diseases including metastatic cancer and obesity. Despite their clinical importance, there is no currently effective pharmacological therapy to regulate functions of lymphatic vessels. Recent efforts to manipulate the Vascular Endothelial Growth Factor-C (VEGFC) pathway, which is arguably the most important signaling pathway regulating lymphatic endothelial cells, to alleviate lymphedema yielded largely mixed results, necessitating identification of new targetable signaling pathways for therapeutic intervention for lymphedema. Zebrafish, a relatively new model system to investigate lymphatic biology, appears to be an ideal model to identify novel therapeutic targets for lymphatic biology. In this review, we will provide an overview of our current understanding of the lymphatic vessels in vertebrates, and discuss zebrafish as a promising in vivo model to study lymphatic vessels.

Successful Control of Lymphatic Filariasis in the Republic of Korea

  • Cheun, Hyeng-Il;Kong, Yoon;Cho, Shin-Hyeong;Lee, Jong-Soo;Chai, Jong-Yil;Lee, Joo-Shil;Lee, Jong-Koo;Kim, Tong-Soo
    • Parasites, Hosts and Diseases
    • /
    • 제47권4호
    • /
    • pp.323-335
    • /
    • 2009
  • A successful experience of lymphatic filariasis control in the Republic of Korea is briefly reviewed. Filariasis in the Republic of Korea was exclusively caused by infection with Brugia malayi. Over the past several decades from the 1950s to 2006, many investigators exerted their efforts to detection, treatment, and follow-up of filariasis patients in endemic areas, and to control filariasis. Mass, combined with selective, treatments with diethylcarbamazine to microfilaria positive persons had been made them free from microfilaremia and contributed to significant decrease of the microfilarial density in previously endemic areas. Significant decrease of microfilaria positive cases in an area influenced eventually to the endemicity of filariasis in the relevant locality. Together with remarkable economic growth followed by improvement of environmental and personal hygiene and living standards, the factors stated above have contributed to blocking the transmission cycle of B. malayi and led to disappearance of this mosquito-borne ancient disease in the Republic of Korea.

폐림프관종증 1예 (Pulmonary Lymphangiomatosis)

  • 조용선;유지홍;손상용;조황래;김수중;한민수;강홍모
    • Tuberculosis and Respiratory Diseases
    • /
    • 제47권4호
    • /
    • pp.533-537
    • /
    • 1999
  • 저자들은 수년동안 반복적으로 유미흉이 재발하였던 31세 여자환자에서 환자의 연령, 임상 양상 등을 고려하여 볼 때 LAM이 의심되었으나, 흉부전산화단층 촬영상 흉막비후와 흉막하 소엽간중격의 비대 소견을 보이고, 낭성병변은 보이지 않으며, 조직검사상 폐실질의 림프혈관들의 확장성 변화를 동반한 증식을 관찰하였으나 평활근의 증식은 동반되지 않았으며 면역조직화학 염색 검사상 HMB-45와 에스트로젠수용체검사에서 음성을 보여 폐림프관종증으로 진단된 1예를 경험하였기에 문헌고찰과 함께 보고하는 바이다.

  • PDF

Effect of anti-skin disorders of ginsenosides- A Systematic Review

  • Lele Cong;Jinli Ma;Yundong Zhang;Yifa Zhou;Xianling Cong;Miao Hao
    • Journal of Ginseng Research
    • /
    • 제47권5호
    • /
    • pp.605-614
    • /
    • 2023
  • Ginsenosides are bioactive components of Panax ginseng with many functions such as anti-aging, anti-oxidation, anti-inflammatory, anti-fatigue, and anti-tumor. Ginsenosides are categorized into dammarane, oleanene, and ocotillol type tricyclic triterpenoids based on the aglycon structure. Based on the sugar moiety linked to C-3, C-20, and C-6, C-20, dammarane type was divided into protopanaxadiol (PPD) and protopanaxatriol (PPT). The effects of ginsenosides on skin disorders are noteworthy. They play antiaging roles by enhancing immune function, resisting melanin formation, inhibiting oxidation, and elevating the concentration of collagen and hyaluronic acid. Thus, ginsenosides have previously been widely used to resist skin diseases and aging. This review details the role of ginsenosides in the anti-skin aging process from mechanisms and experimental research.

폐림프관종증 1예 (A Case of Pulmonary Lymphangiomatosis)

  • 장은경;김창래;최창민;오연목;심태선;이상도;김우성;김동순;송진우
    • Tuberculosis and Respiratory Diseases
    • /
    • 제70권5호
    • /
    • pp.428-432
    • /
    • 2011
  • Pulmonary lymphangiomatosis is a rare disorder involving the entire intrathoracic lymphatic system from the mediastinum to the pleura. Pulmonary lymphangiomatosis mostly occurs in children and young adults without gender predilection. Although it is pathologically benign, it shows a progressive and fatal course with variable initial presentation. We now report a case of pulmonary lymphangiomatosis in a 35-year-old man. He presented with hemoptysis 6 months previously. Chest x-ray and a chest computed tomography scan showed diffuse interstitial thickening with left pleural effusion. Chylothorax was confirmed by thoracentesis. Lymphangiography showed dilated and tortuous lymphatic channels. Surgical lung biopsy revealed proliferation of complex anastomosing lymphatic channels. He was diagnosed with pulmonary lymophangiomatosis. Closed thoracostomy and chemical pleurodesis were done and the dyspnea was reduced.

Proximal ligation after the side-to-end anastomosis recovery technique for lymphaticovenous anastomosis

  • Suzuki, Yushi;Sakuma, Hisashi;Ihara, Jun;Shimizu, Yusuke
    • Archives of Plastic Surgery
    • /
    • 제46권4호
    • /
    • pp.344-349
    • /
    • 2019
  • Background Lymphaticovenous anastomosis is an important surgical treatment for lymphedema, with lymphaticovenous side-to-end anastomosis (LVSEA) and lymphaticovenous end-to-end anastomosis being the most frequently performed procedures. However, LVSEA can cause lymphatic flow obstruction because of regurgitation and tension in the anastomosis. In this study, we introduce a novel and simple procedure to overcome this problem. Methods Thirty-five female patients with lower extremity lymphedema who underwent lymphaticovenous anastomosis at our hospital were included in this study. Eighty-five LVSEA procedures were performed, of which 12 resulted in insufficient venous blood flow. For these 12 anastomoses, the proximal lymphatic vessel underwent clipping after the anastomotic procedure and the venous inflow was monitored. Subsequently, the proximal ligation after side-to-end anastomosis recovery (PLASTER) technique, which involves ligating the proximal side of the lymphatic vessel, was applied. A postoperative evaluation was performed using indocyanine green 6 months after surgery. Results Despite the clipping procedure, three of the 12 anastomoses still showed poor venous inflow. Therefore, it was not possible to apply the PLASTER technique in those cases. Among the nine remaining anastomoses in which the PLASTER technique was applied, three (33%) were patent. Conclusions Our findings show that achieving patent anastomosis is challenging when postoperative venous inflow is poor. We achieved good results by performing proximal ligation after LVSEA. Thus, the PLASTER technique is a particularly useful recovery technique when LVSEA does not result in good run-off.

복부 림프절의 명명법 및 림프 배액 패턴 (Nomenclature and Lymphatic Drainage Patterns of Abdominal Lymph Nodes)

  • 조현석;안지현
    • 대한영상의학회지
    • /
    • 제83권6호
    • /
    • pp.1240-1258
    • /
    • 2022
  • 림프계는 염증 및 악성 세포의 확산 경로를 제공한다. 종양이 확산되는 림프절의 위치와 림프 배액 경로를 인지하는 것은 종양의 병기 결정, 치료 방법 선택 및 환자의 예후 예측에 중요하다. 복강 내 악성 종양에서 림프절 전이는 흔하기 때문에 림프절 전이를 발견하고 질병의 확산 방식을 이해하는 것은 영상의학과 의사에게 필수적이다. 이 임상화보에서는 도식적인 그림들과 림프절을 색으로 표시한 CT 영상을 사용하여, 상부 및 하부 위장관, 간, 담낭, 담관 및 췌장의 림프절 위치와 이름, 그리고 림프 배수 경로에 관해 기술하였다. 또한 각 장기에서 발생하는 악성 종양의 국소 림프절의 종류에 대해 기술하고 몇몇 증례의 영상을 제시하였다.